Sanofi Consumer Healthcare India Ltd (SANOFICONR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039387,
    "name": "Sanofi Consumer",
    "stock_name": "Sanofi Consumer",
    "full_name": "Sanofi Consumer Healthcare India Ltd",
    "name_url": "stocks-analysis/sanofi-consumer",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,363.90",
    "chg": 121.15,
    "chgp": "2.86%",
    "dir": 1,
    "prev_price": "4,242.75",
    "mcapval": "9,823.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544250,
    "symbol": "SANOFICONR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0UOS01011",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "4.55 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sanofi-consumer-10039387-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Sanofi Consumer technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sanofi-consumer-technically-bullish-or-bearish-3743211",
        "imagepath": "",
        "date": "2025-12-03 08:59:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Shift and Momentum Indicators</strong></p>\n<p>As of 2 December 2025, Sanofi Consumer’s technical trend has transitioned from mildly bearish to outright bearish. This shift is underscored by several key technical indicators. The Moving Average Convergence Divergence (MACD) on the weekly chart is firmly bearish, indicating downward momentum in the medium term. Similarly, the Bollinger Bands on the weekly timeframe suggest the stock is trading near the lower band, a sign of sustained selling pressure.</p>\n<p>Daily moving averages also reinforce the bearish outlook, with the stock price positioned below key averages, signalling a lack of short-term buying interest. The Know Sure Thing (KST) indicator on the weekly chart aligns with this negative momentum, further confirming the d..."
      },
      {
        "title": "Sanofi Consumer Healthcare India Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanofi-consumer-healthcare-india-faces-bearish-momentum-amid-technical-downturn-3743096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanofiConsumerH_technicaldot_3743096.png",
        "date": "2025-12-03 08:09:52",
        "description": "Sanofi Consumer Healthcare India is exhibiting a shift in technical momentum, with recent evaluation adjustments signalling a bearish trend across multiple timeframes. The stock’s price action and key technical indicators suggest a cautious outlook as it navigates resistance levels and market pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sanofi Consumer Healthcare India Faces Technical Momentum Shift Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanofi-consumer-healthcare-india-faces-technical-setbacks-amid-weak-price-momentum-3740501",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanofiConsumerH_technicaldot_3740501.png",
        "date": "2025-12-02 08:13:47",
        "description": "Sanofi Consumer Healthcare India has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a nuanced change in the stock’s trend, warranting close attention from investors and market analysts alike."
      },
      {
        "title": "Sanofi Consumer’s Evaluation Revised Amidst Valuation and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanofi-consumer-downgraded-to-sell-by-marketsmojo-amid-valuation-and-technical-concerns-3733242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanofiConsumer_mojoScore_3733242.png",
        "date": "2025-11-27 10:05:37",
        "description": "Sanofi Consumer has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters including valuation, financial trends, technical outlook, and quality metrics. This adjustment comes amid a backdrop of subdued stock performance and sector-specific pressures within the Pharmaceuticals & Biotechnology industry."
      },
      {
        "title": "Sanofi Consumer Healthcare India Reports Strong Financial Performance Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanofi-consumer-healthcare-indias-financial-trend-shifts-from-flat-to-positive-with-record-sales-3701331",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanofiConsumerH_fintrenddot_3701331.png",
        "date": "2025-11-14 11:03:33",
        "description": "Sanofi Consumer Healthcare India reported strong financial results for the quarter ending September 2025, achieving record net sales of Rs 233.90 crore and a profit before tax of Rs 81.10 crore. The company demonstrated resilience in the pharmaceuticals sector despite experiencing stock volatility and market fluctuations."
      },
      {
        "title": "Sanofi Consumer Healthcare India Q2 FY26: Premium Valuation Meets Robust Growth, But Concerns Linger",
        "link": "https://www.marketsmojo.com/news/result-analysis/sanofi-consumer-healthcare-india-q2-fy26-premium-valuation-meets-robust-growth-but-concerns-linger-3715600",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanofiConsumerH_quaterlyResult_3715600.png",
        "date": "2025-11-14 09:46:34",
        "description": "Sanofi Consumer Healthcare India Ltd. reported a strong performance in Q2 FY26, with net profit reaching ₹62.90 crores, marking a sequential increase of 3.62% from Q1 FY26's ₹60.70 crores and an impressive year-on-year surge of 39.78% from ₹45.00 crores in Q2 FY25. The company, with a market capitalisation of ₹11,151.43 crores, continues to demonstrate operational resilience despite trading at elevated valuations. However, the stock has faced headwinds, declining 2.90% to ₹4,842.00 following the results announcement, reflecting investor concerns about premium pricing and technical weakness."
      },
      {
        "title": "Why is Sanofi Consumer falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sanofi-consumer-fallingrising-3699961",
        "imagepath": "",
        "date": "2025-11-14 00:09:08",
        "description": "As of 13-Nov, Sanofi Consumer Healthcare India Ltd's stock price is rising, currently at 4,986.40, reflecting an increase of 329.1 or 7.07%. The stock has outperformed its sector by 7.13% today and has experienced consecutive gains over the last two days, with an overall return of 8.63% during this period. It reached an intraday high of Rs 5072.45, indicating strong upward momentum. Despite this positive movement, there is a notable decline in investor participation, with delivery volume falling by 80.89% against the five-day average. The company boasts high management efficiency with a return on equity (ROE) of 73.93% and a low debt-to-equity ratio, which supports its healthy long-term growth, evidenced by significant increases in net sales and operating profit. However, the stock's valuation is considered very expensive, with a price-to-book value of 44.7, and its profits have decreased by 27% over the pa..."
      },
      {
        "title": "How has been the historical performance of Sanofi Consumer?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sanofi-consumer-3699864",
        "imagepath": "",
        "date": "2025-11-13 23:53:31",
        "description": "Answer:\nThe historical performance of Sanofi Consumer for the year ending December 2024 shows significant growth in various financial metrics compared to the previous year.\n\nBreakdown:\nIn December 2024, Sanofi Consumer reported net sales of 724.50 crore, with total operating income also at 724.50 crore. The total expenditure, excluding depreciation, was 453.90 crore, leading to an operating profit (PBDIT) of 283.60 crore. After accounting for interest and exceptional items, the profit before tax stood at 246.80 crore, resulting in a profit after tax of 181.00 crore. The earnings per share (EPS) was reported at 78.7, with a PAT margin of 24.98%. On the balance sheet, shareholder's funds increased to 273.00 crore from 207.60 crore in the previous year, while total liabilities rose to 425.10 crore from 343.50 crore. The total assets also increased to 425.10 crore, with cash and bank balances significantly risi..."
      },
      {
        "title": "Sanofi Consumer Healthcare Hits Day High with 8.69% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanofi-consumer-healthcare-hits-day-high-with-869-intraday-surge-3696880",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanofiConsumerH_priceRelatedfactors_3696880.png",
        "date": "2025-11-13 09:42:37",
        "description": "Sanofi Consumer Healthcare India has demonstrated strong performance, achieving consecutive gains over two days and significantly outperforming its sector. The stock is trading above key moving averages, indicating robust trends. Despite a slight decline in the broader market, the company shows resilience and positive momentum."
      }
    ],
    "total": 80,
    "sid": "10039387",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/sanofi-consumer-healthcare-india-10039387"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2025 is enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation for Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Newspaper publication for the quarter and nine months ended Unaudited Financial Results 30 September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanofi Consumer Healthcare India Ltd has declared <strong>550%</strong> dividend, ex-date: 17 Apr 25",
          "dt": "2025-04-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Sanofi Consumer technically bullish or bearish?

2025-12-03 08:59:46

Technical Trend Shift and Momentum Indicators As of 2 December 2025, Sanofi Consumer’s technical trend has transitioned from mildly bearish to outright bearish. This shift is underscored by several key technical indicators. The Moving Average Convergence Divergence (MACD) on the weekly chart is firmly bearish, indicating downward momentum in the medium term. Similarly, the Bollinger Bands on the weekly timeframe suggest the stock is trading near the lower band, a sign of sustained selling pressure. Daily moving averages also reinforce the bearish outlook, with the stock price positioned below key averages, signalling a lack of short-term buying interest. The Know Sure Thing (KST) indicator on the weekly chart aligns with this negative momentum, further confirming the d...

Sanofi Consumer Healthcare India Faces Bearish Momentum Amid Technical Shifts

2025-12-03 08:09:52

Sanofi Consumer Healthcare India is exhibiting a shift in technical momentum, with recent evaluation adjustments signalling a bearish trend across multiple timeframes. The stock’s price action and key technical indicators suggest a cautious outlook as it navigates resistance levels and market pressures within the Pharmaceuticals & Biotechnology sector.

Sanofi Consumer Healthcare India Faces Technical Momentum Shift Amid Market Challenges

2025-12-02 08:13:47

Sanofi Consumer Healthcare India has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a nuanced change in the stock’s trend, warranting close attention from investors and market analysts alike.

Sanofi Consumer’s Evaluation Revised Amidst Valuation and Market Challenges

2025-11-27 10:05:37

Sanofi Consumer has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters including valuation, financial trends, technical outlook, and quality metrics. This adjustment comes amid a backdrop of subdued stock performance and sector-specific pressures within the Pharmaceuticals & Biotechnology industry.

Sanofi Consumer Healthcare India Reports Strong Financial Performance Amid Market Volatility

2025-11-14 11:03:33

Sanofi Consumer Healthcare India reported strong financial results for the quarter ending September 2025, achieving record net sales of Rs 233.90 crore and a profit before tax of Rs 81.10 crore. The company demonstrated resilience in the pharmaceuticals sector despite experiencing stock volatility and market fluctuations.

Sanofi Consumer Healthcare India Q2 FY26: Premium Valuation Meets Robust Growth, But Concerns Linger

2025-11-14 09:46:34

Sanofi Consumer Healthcare India Ltd. reported a strong performance in Q2 FY26, with net profit reaching ₹62.90 crores, marking a sequential increase of 3.62% from Q1 FY26's ₹60.70 crores and an impressive year-on-year surge of 39.78% from ₹45.00 crores in Q2 FY25. The company, with a market capitalisation of ₹11,151.43 crores, continues to demonstrate operational resilience despite trading at elevated valuations. However, the stock has faced headwinds, declining 2.90% to ₹4,842.00 following the results announcement, reflecting investor concerns about premium pricing and technical weakness.

Why is Sanofi Consumer falling/rising?

2025-11-14 00:09:08

As of 13-Nov, Sanofi Consumer Healthcare India Ltd's stock price is rising, currently at 4,986.40, reflecting an increase of 329.1 or 7.07%. The stock has outperformed its sector by 7.13% today and has experienced consecutive gains over the last two days, with an overall return of 8.63% during this period. It reached an intraday high of Rs 5072.45, indicating strong upward momentum. Despite this positive movement, there is a notable decline in investor participation, with delivery volume falling by 80.89% against the five-day average. The company boasts high management efficiency with a return on equity (ROE) of 73.93% and a low debt-to-equity ratio, which supports its healthy long-term growth, evidenced by significant increases in net sales and operating profit. However, the stock's valuation is considered very expensive, with a price-to-book value of 44.7, and its profits have decreased by 27% over the pa...

How has been the historical performance of Sanofi Consumer?

2025-11-13 23:53:31

Answer: The historical performance of Sanofi Consumer for the year ending December 2024 shows significant growth in various financial metrics compared to the previous year. Breakdown: In December 2024, Sanofi Consumer reported net sales of 724.50 crore, with total operating income also at 724.50 crore. The total expenditure, excluding depreciation, was 453.90 crore, leading to an operating profit (PBDIT) of 283.60 crore. After accounting for interest and exceptional items, the profit before tax stood at 246.80 crore, resulting in a profit after tax of 181.00 crore. The earnings per share (EPS) was reported at 78.7, with a PAT margin of 24.98%. On the balance sheet, shareholder's funds increased to 273.00 crore from 207.60 crore in the previous year, while total liabilities rose to 425.10 crore from 343.50 crore. The total assets also increased to 425.10 crore, with cash and bank balances significantly risi...

Sanofi Consumer Healthcare Hits Day High with 8.69% Intraday Surge

2025-11-13 09:42:37

Sanofi Consumer Healthcare India has demonstrated strong performance, achieving consecutive gains over two days and significantly outperforming its sector. The stock is trading above key moving averages, indicating robust trends. Despite a slight decline in the broader market, the company shows resilience and positive momentum.

View All News